1Q22 MD&A Advanced Info Service Plc. Executive Summary Prolonged economic impact from Omicron outbreak and rising inflation in 1Q22 In 1Q22, Thailand’s economic recovery was challenged as private
Executive Summary and Management Guidelines to Mitigate the Effects of the COVID-19 Outbreak 03 Statement of Income 09 Business Performance 11 Statement of Financial Position 24 Cash of Statement 26 Financial
the COVID-19 Outbreak 03 Statement of Income 09 Business Performance 11 Statement of Financial Position 24 Cash of Statement 26 Financial Ratios 27 Environment Management Accounting 29 3 Management
-19 Outbreak 03 Statement of Income 09 Business Performance 11 Statement of Financial Position 24 Cash of Statement 26 Financial Ratios 27 Environment Management Accounting 29 3 Management Discussion
-19 Outbreak 03 Statement of Income 09 Business Performance 11 Statement of Financial Position 24 Cash of Statement 26 Financial Ratios 27 Environment Management Accounting 29 3 Management Discussion
. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
tons, dropped by 11,000 tons or 3% from the previous quarter due to the spread of COVID-19 outbreak, resulted in the lessen transport in logistic and private sector as well as temporarily shut down or
Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the